Nice, only company that showed revenue #s which I listed below which double of Stem Cell Group and market cap is $392mill
Market cap: $392.71 million; current share price: $11.25
Vericel bases its treatment in tissue collection from the patient. Its two lead products, Carticel and Epicel, are seeking to treat cartilage defects in the knee and patients with burns greater than or equal to 30 percent of total body surface area respectively.
The company initiated a collaboration with the private company Innovative Cellular Therapeutics. Vericel has the intention to use the collaboration to bring its cell therapy products to patients in Asia.
In March, the company announced positive 2017 financial results with an 18 percent increase to $63.9 million from $54.4 million year over y